Skip to main content
Erschienen in: American Journal of Clinical Dermatology 1/2012

01.02.2012 | Original Research Article

Atopic Dermatitis and Risk of Skin Cancer

A Danish Nationwide Cohort Study (1977–2006)

verfasst von: Dr Annette O. Jensen, Claus Svaerke, Dora Körmendiné Farkas, Anne B. Olesen, Knud Kragballe, Henrik T. Sørensen

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background: Recent data suggest a reduced risk of malignant melanoma (MM) among atopic dermatitis (AD) patients, but an increased risk of other skin cancers (including basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]).
Objective: We examined the association between AD and skin cancers in a large cohort study in Denmark from 1977 through 2006.
Methods: Our cohort consisted of 31 330 AD patients recorded in the Danish National Patient Registry, including AD patients admitted to hospitals and specialized outpatient clinics. Linkage to the Danish Cancer Registry allowed ascertainment of skin cancers. We calculated standardized incidence ratios (SIRs) and associated 95% confidence intervals (CIs) by comparing the incidence rate of skin cancers among AD patients with that among the general Danish population.
Results: The overall observed number of MM cases among AD patients was 12, with 21 expected, yielding a SIR of 0.59 (95% CI 0.30, 1.02), with the most pronounced protective effect among AD patients with more than 5 years of follow-up (SIR = 0.46; 95% CI 0.19, 0.95). The corresponding SIRs for BCC and SCC were increased among AD patients (1.41 [95% CI 1.07, 1.83] and 2.48 [95% CI 1.00, 5.11], respectively).
Conclusions: Our findings support an inverse association between AD and MM, but an increased risk of BCC and SCC among AD patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Keil T, Kulig M, Simpson A, et al. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs: a GALEN initiative. Allergy 2006 Feb; 61 (2): 221–8 Keil T, Kulig M, Simpson A, et al. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs: a GALEN initiative. Allergy 2006 Feb; 61 (2): 221–8
2.
Zurück zum Zitat Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol 2008; 624: 89–103PubMedCrossRef Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol 2008; 624: 89–103PubMedCrossRef
3.
Zurück zum Zitat Synnerstad I, Fredrikson M, Ternesten-Bratel A, et al. Low risk of melanoma in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2008 Dec; 22 (12): 1423–8 Synnerstad I, Fredrikson M, Ternesten-Bratel A, et al. Low risk of melanoma in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2008 Dec; 22 (12): 1423–8
4.
Zurück zum Zitat Hagstromer L, Ye W, Nyren O, et al. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005 Sep; 141 (9): 1123–7 Hagstromer L, Ye W, Nyren O, et al. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005 Sep; 141 (9): 1123–7
5.
Zurück zum Zitat Olesen AB, Engholm G, Storm HH, et al. The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol 2005 Sep; 125 (3): 445–9 Olesen AB, Engholm G, Storm HH, et al. The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol 2005 Sep; 125 (3): 445–9
6.
Zurück zum Zitat Ji J, Shu X, Li X, et al. Cancer risk in hospitalised asthma patients. Br J Cancer 2009 Mar 10; 100 (5): 829–33 Ji J, Shu X, Li X, et al. Cancer risk in hospitalised asthma patients. Br J Cancer 2009 Mar 10; 100 (5): 829–33
7.
Zurück zum Zitat Frank L. Epidemiology: when an entire country is a cohort. Science 2000 Mar 31; 287 (5462): 2398–9 Frank L. Epidemiology: when an entire country is a cohort. Science 2000 Mar 31; 287 (5462): 2398–9
8.
Zurück zum Zitat Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999 Jun; 46 (3): 263–8 Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999 Jun; 46 (3): 263–8
9.
Zurück zum Zitat Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003 Oct 6; 89 (7): 1221–7 Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003 Oct 6; 89 (7): 1221–7
10.
Zurück zum Zitat Jensen AO, Olesen AB, Dethlefsen C, et al. Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers: a population based study from Denmark. J Invest Dermatol 2008 Apr; 128 (4): 926–31 Jensen AO, Olesen AB, Dethlefsen C, et al. Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers: a population based study from Denmark. J Invest Dermatol 2008 Apr; 128 (4): 926–31
11.
Zurück zum Zitat Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997 Nov; 44 (5): 535–9 Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997 Nov; 44 (5): 535–9
12.
Zurück zum Zitat Breslow NE, Day NE. Statistical methods in cancer research: volume II. The design and analysis of cohort studies. IARC Sci Publ 1987; (82): 1–406 Breslow NE, Day NE. Statistical methods in cancer research: volume II. The design and analysis of cohort studies. IARC Sci Publ 1987; (82): 1–406
13.
Zurück zum Zitat Rothman KJ. Epidemiology: an introduction. New York (NY): Oxford University Press, 2002 Rothman KJ. Epidemiology: an introduction. New York (NY): Oxford University Press, 2002
14.
Zurück zum Zitat Mittelman A, Chen ZJ, Liu CC, et al. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res 1994 Jan 15; 54 (2): 415–21 Mittelman A, Chen ZJ, Liu CC, et al. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res 1994 Jan 15; 54 (2): 415–21
15.
Zurück zum Zitat Mukherji B, Chakraborty NG. Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 1995 Mar; 7 (2): 175–84 Mukherji B, Chakraborty NG. Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 1995 Mar; 7 (2): 175–84
16.
Zurück zum Zitat Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004 Mar; 113 (5): 651–7 Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004 Mar; 113 (5): 651–7
17.
Zurück zum Zitat Swope VB, Abdel-Malek Z, Kassem LM, et al. Interleukins 1 alpha and 6 a nd tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991 Feb; 96 (2): 180–5 Swope VB, Abdel-Malek Z, Kassem LM, et al. Interleukins 1 alpha and 6 a nd tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991 Feb; 96 (2): 180–5
18.
Zurück zum Zitat Krasagakis K, Garbe C, Eberle J, et al. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res 1995; 287 (3-4): 259–65PubMedCrossRef Krasagakis K, Garbe C, Eberle J, et al. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res 1995; 287 (3-4): 259–65PubMedCrossRef
19.
Zurück zum Zitat Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000 Feb; 142 (2): 306–9 Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000 Feb; 142 (2): 306–9
20.
Zurück zum Zitat Swerdlow AJ, English J, MacKie RM, et al. Benign naevi associated with high risk of melanoma [letter]. Lancet 1984 Jul 21; 2 (8395): 168 Swerdlow AJ, English J, MacKie RM, et al. Benign naevi associated with high risk of melanoma [letter]. Lancet 1984 Jul 21; 2 (8395): 168
21.
Zurück zum Zitat Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987 Sep; 17 (3): 459–68 Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987 Sep; 17 (3): 459–68
22.
Zurück zum Zitat Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984 Feb; 72 (2): 257–66 Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984 Feb; 72 (2): 257–66
23.
Zurück zum Zitat Lea CS, Scotto JA, Buffler PA, et al. Ambient UVB and melanoma risk in the United States: a case-control analysis. Ann Epidemiol 2007 Jun; 17 (6): 447–53 Lea CS, Scotto JA, Buffler PA, et al. Ambient UVB and melanoma risk in the United States: a case-control analysis. Ann Epidemiol 2007 Jun; 17 (6): 447–53
24.
Zurück zum Zitat Sorensen HT, Mellemkjaer L, Nielsen GL, et al. Skin cancers and non- Hodgkin lymphoma among users of systemic glucocorticoids: a populationbased cohort study. J Natl Cancer Inst 2004 May 5; 96 (9): 709–11 Sorensen HT, Mellemkjaer L, Nielsen GL, et al. Skin cancers and non- Hodgkin lymphoma among users of systemic glucocorticoids: a populationbased cohort study. J Natl Cancer Inst 2004 May 5; 96 (9): 709–11
25.
Zurück zum Zitat Jensen AO, Thomsen HF, Engebjerg MC, et al. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkins lymphoma: a population-based case-control study. Br J Cancer 2009 Jan 13; 100 (1): 200–5 Jensen AO, Thomsen HF, Engebjerg MC, et al. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkins lymphoma: a population-based case-control study. Br J Cancer 2009 Jan 13; 100 (1): 200–5
26.
Zurück zum Zitat Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet Feb 20; 375 (9715): 673–85 Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet Feb 20; 375 (9715): 673–85
27.
Zurück zum Zitat Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-Alight (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA Follow-up Study. J Natl Cancer Inst 1998 Sep 2; 90 (17): 1278–84 Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-Alight (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA Follow-up Study. J Natl Cancer Inst 1998 Sep 2; 90 (17): 1278–84
28.
Zurück zum Zitat Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study Helios: II. Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996 Jun; 73 (11): 1447–54 Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study Helios: II. Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996 Jun; 73 (11): 1447–54
29.
Zurück zum Zitat Ming ME, Levy R, Hoffstad O, et al. The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol 2004 Mar; 50 (3): 357–62 Ming ME, Levy R, Hoffstad O, et al. The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol 2004 Mar; 50 (3): 357–62
30.
Zurück zum Zitat Olesen AB, Ellingsen AR, Olesen H, et al. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ 1997 Apr 5; 314 (7086): 1003–8 Olesen AB, Ellingsen AR, Olesen H, et al. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ 1997 Apr 5; 314 (7086): 1003–8
31.
Zurück zum Zitat Mills CM, Srivastava ED, Harvey IM, et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994 Jan; 33 (1): 33–4 Mills CM, Srivastava ED, Harvey IM, et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994 Jan; 33 (1): 33–4
Metadaten
Titel
Atopic Dermatitis and Risk of Skin Cancer
A Danish Nationwide Cohort Study (1977–2006)
verfasst von
Dr Annette O. Jensen
Claus Svaerke
Dora Körmendiné Farkas
Anne B. Olesen
Knud Kragballe
Henrik T. Sørensen
Publikationsdatum
01.02.2012
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 1/2012
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/11593280-000000000-00000

Weitere Artikel der Ausgabe 1/2012

American Journal of Clinical Dermatology 1/2012 Zur Ausgabe

Review Article

Body Piercing

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.